CN106164136B - 涉及稳定化聚合硅酸盐组合物的材料和方法 - Google Patents

涉及稳定化聚合硅酸盐组合物的材料和方法 Download PDF

Info

Publication number
CN106164136B
CN106164136B CN201580018382.3A CN201580018382A CN106164136B CN 106164136 B CN106164136 B CN 106164136B CN 201580018382 A CN201580018382 A CN 201580018382A CN 106164136 B CN106164136 B CN 106164136B
Authority
CN
China
Prior art keywords
silicate
composition
compositions
stabilized polymeric
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580018382.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN106164136A (zh
Inventor
卡洛斯·安德烈·帕索斯·巴斯托斯
乔纳森·约瑟夫·鲍威尔
努诺·若热·罗德里格斯·法里亚
布雷德利·迈克尔·维什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
British Research And Innovation Agency
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of CN106164136A publication Critical patent/CN106164136A/zh
Application granted granted Critical
Publication of CN106164136B publication Critical patent/CN106164136B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/02—Polysilicates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/34—Silicon-containing compounds
    • C08K3/36—Silica
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/02—Polysilicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00—Specific properties of additives
    • C08K2201/011—Nanostructured additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
CN201580018382.3A 2014-02-14 2015-02-13 涉及稳定化聚合硅酸盐组合物的材料和方法 Active CN106164136B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1402672.8 2014-02-14
GB201402672A GB201402672D0 (en) 2014-02-14 2014-02-14 Materials and methods relating to stabilised polymeric silicate compositions
PCT/GB2015/050409 WO2015121666A1 (en) 2014-02-14 2015-02-13 Materials and methods relating to stabilised polymeric silicate compositions

Publications (2)

Publication Number Publication Date
CN106164136A CN106164136A (zh) 2016-11-23
CN106164136B true CN106164136B (zh) 2019-11-08

Family

ID=50440204

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580018382.3A Active CN106164136B (zh) 2014-02-14 2015-02-13 涉及稳定化聚合硅酸盐组合物的材料和方法

Country Status (13)

Country Link
US (4) US20170042934A1 (enExample)
EP (1) EP3105281B1 (enExample)
JP (1) JP6618475B2 (enExample)
KR (1) KR102354909B1 (enExample)
CN (1) CN106164136B (enExample)
AU (1) AU2015216711B2 (enExample)
CA (1) CA2939419C (enExample)
EA (1) EA034577B1 (enExample)
ES (1) ES2872498T3 (enExample)
GB (1) GB201402672D0 (enExample)
NZ (1) NZ723746A (enExample)
SG (2) SG10202000307VA (enExample)
WO (1) WO2015121666A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2652114T3 (es) 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
WO2017173317A1 (en) * 2016-04-01 2017-10-05 Nickels Daniel Novel bone putty compositions and methods of use thereof
US10604257B2 (en) * 2016-06-28 2020-03-31 International Business Machines Corporation Unmanned aerial vehicle for air sampling
JP7510254B2 (ja) * 2016-08-10 2024-07-03 ユナイテッド キングダム リサーチ アンド イノベーション ナノシリカ粒子を含む組成物および療法のためにｔリンパ球を活性化する方法におけるそれらの使用
KR20180034937A (ko) 2016-09-28 2018-04-05 모멘티브퍼포먼스머티리얼스코리아 주식회사 유기 전자 소자 봉지재용 조성물 및 이를 이용하여 형성된 봉지재
GB201701944D0 (en) * 2017-02-06 2017-03-22 Medical Res Council Antimicrobial compositions and their uses
KR102427987B1 (ko) 2018-11-27 2022-08-02 주식회사 엘지화학 전가수분해된 폴리실리케이트의 합성방법
KR102207608B1 (ko) * 2019-04-24 2021-01-26 윤종오 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
WO2020218834A1 (ko) * 2019-04-24 2020-10-29 윤종오 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
US20230021329A1 (en) * 2019-12-20 2023-01-26 Veri Nano Inc. Nanostructured binary gel composition and use thereof
SE2450523A1 (en) * 2024-02-22 2025-08-23 Lea Cares Ab Method to form supernatant
WO2025178550A1 (en) * 2024-02-22 2025-08-28 Lea Cares Ab Method to form supernatant
CN119660919A (zh) * 2024-12-19 2025-03-21 河北清泓检测技术服务有限公司 一种适应高温高pH值的絮凝剂复配方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1693195A (zh) * 2004-05-09 2005-11-09 中国石化北京燕化石油化工股份有限公司 适用于阴离子聚合的层状硅酸盐的改性方法、由此得到的改性层状硅酸盐及其用途
CN101142140A (zh) * 2005-01-18 2008-03-12 维多利亚链接有限公司 一种纳米结构硅酸盐及其功能化形式、制备和应用
CN101370855A (zh) * 2006-01-12 2009-02-18 优尼士化学解决方案有限公司 使用pH值调节呈溶液形式的碱金属硅酸盐的聚合度的方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1688228A (en) 1928-10-16 gebmany
US4029770A (en) 1974-03-26 1977-06-14 Caw Industries, Inc. Method of therapeutically treating damaged and/or infected tissue and relieving stress and shock in warm blooded animals
US4563351A (en) 1983-08-01 1986-01-07 Forsyth Dental Infirmary For Children Self-gelling therapeutic compositions for topical application
US5080900A (en) 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash
US7014870B1 (en) 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
DK0668769T3 (da) 1992-11-06 2000-10-02 Greystone Medical Group Inc Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
US5370876A (en) 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
NL9400189A (nl) 1994-02-07 1995-09-01 Bio Pharma Sciences Bv Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat.
US20060246154A1 (en) 1997-10-08 2006-11-02 Hon David N Composition of oak bark extract, related synthetic compositions, and method of using same
FR2799758B1 (fr) 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
CA2298762C (en) 2000-02-11 2001-06-12 Paul M. Pidcock Therapeutic compositions consisting of clarified multi-filtered soluable sodium silicate in liquid form are found to modify suppressor cells and enhanse the human immune system toprevent recurrence of herpes infections
KR100330993B1 (ko) 2000-02-18 2002-04-01 김승일 액상 사료 첨가제 및 이의 제조방법
RU2182006C2 (ru) 2000-03-01 2002-05-10 Цивинский Станислав Викторович Способ лечения ревматоидного артрита
US6692775B2 (en) 2000-03-13 2004-02-17 Aqua Med, Inc. Bactericidal gel and method for treating burns and dermal lesions
US6288045B1 (en) 2000-06-09 2001-09-11 Lifelink Pharmaceuticals, Inc. Epithelial cell cancer drug
KR100331952B1 (ko) 2000-11-23 2002-04-09 최수일 다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도
US20040057958A1 (en) 2002-05-17 2004-03-25 Waggoner David W. Immunogenicity-enhancing carriers and compositions thereof and methods of using the same
UA80969C2 (en) 2002-05-31 2007-11-26 Aqueous solution of non-colloidal silicic and boric acids, method for its preparation and application
US20040097467A1 (en) 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
RU2237483C1 (ru) 2003-02-21 2004-10-10 Цивинский Станислав Викторович Средство для лечения гастрита с повышенной кислотностью и язвенной болезни и способ их лечения
US8187473B2 (en) 2003-05-15 2012-05-29 Kanumuru Rahul Raju Functional transition metal silicates
CN1315484C (zh) 2004-11-16 2007-05-16 关相龙 治疗皮肤病的药物载体组合物及制备方法
RU2280458C1 (ru) 2004-11-30 2006-07-27 Алевтина Ивановна Косолапова Противовоспалительная мазь
DE102004063599B4 (de) 2004-12-30 2007-07-12 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese
WO2006136003A1 (en) 2005-04-20 2006-12-28 Laboratoires Mauves Inc. Organic silicic acids complex for therapeutic and cosmetic applications
WO2008147468A2 (en) 2006-12-18 2008-12-04 Amcol International Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use
US20100278935A1 (en) 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
ES2652114T3 (es) 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
US20110009486A1 (en) 2008-03-03 2011-01-13 Luna Innovations Incorporated Method for treating pruritus by administering fullerenes
WO2009127256A1 (en) * 2008-04-17 2009-10-22 Jisbrey, S.A Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use
EP2151466A1 (en) 2008-08-01 2010-02-10 SiNatur GmbH Biologically active silicic acid
EP2371220B2 (en) * 2010-03-31 2018-01-17 Taminco Stabilized bio-available soluble silicate solution
US9345720B2 (en) * 2010-10-26 2016-05-24 Exeltis Usa Dermatology, Inc. Composition and method for treating wounds
GB201402669D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Stabilised silicate compositions and their uses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1693195A (zh) * 2004-05-09 2005-11-09 中国石化北京燕化石油化工股份有限公司 适用于阴离子聚合的层状硅酸盐的改性方法、由此得到的改性层状硅酸盐及其用途
CN101142140A (zh) * 2005-01-18 2008-03-12 维多利亚链接有限公司 一种纳米结构硅酸盐及其功能化形式、制备和应用
CN101370855A (zh) * 2006-01-12 2009-02-18 优尼士化学解决方案有限公司 使用pH值调节呈溶液形式的碱金属硅酸盐的聚合度的方法

Also Published As

Publication number Publication date
GB201402672D0 (en) 2014-04-02
US20190224233A1 (en) 2019-07-25
CA2939419C (en) 2022-07-26
EP3105281A1 (en) 2016-12-21
AU2015216711A1 (en) 2016-09-22
US20240066053A1 (en) 2024-02-29
HK1226424A1 (zh) 2017-09-29
SG10202007920RA (en) 2020-10-29
WO2015121666A1 (en) 2015-08-20
KR102354909B1 (ko) 2022-01-24
KR20160124797A (ko) 2016-10-28
JP6618475B2 (ja) 2019-12-11
CN106164136A (zh) 2016-11-23
EP3105281B1 (en) 2021-04-21
NZ723746A (en) 2022-09-30
SG10202000307VA (en) 2020-03-30
AU2015216711B2 (en) 2018-08-09
EA201691441A1 (ru) 2017-02-28
ES2872498T3 (es) 2021-11-02
US10898511B2 (en) 2021-01-26
JP2017512189A (ja) 2017-05-18
US11833171B2 (en) 2023-12-05
CA2939419A1 (en) 2015-08-20
EA034577B1 (ru) 2020-02-21
US20210145866A1 (en) 2021-05-20
US20170042934A1 (en) 2017-02-16

Similar Documents

Publication Publication Date Title
US20240066053A1 (en) Materials and Methods Relating to Stabilised Polymeric Silicate Compositions
CN106102694B (zh) 稳定化硅酸盐组合物及其作为止汗组合物的用途
Pal et al. Synthesis of highly antibacterial nanocrystalline trivalent silver polydiguanide
US11980637B2 (en) Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
HK1216720A1 (zh) 用於递送治疗剂的可生物蚀解的硅基组合物
WO2016181935A1 (ja) グルココルチコステロイドのナノ微粒子を含有する水性懸濁液剤
JP5568114B2 (ja) 抗菌性製剤の輸液を調製するための医薬組成物、その製造方法
JP7158039B2 (ja) ゾル－ゲル／ヒドロゲル治療薬送達システム及びその方法
HK1226424B (en) Materials and methods relating to stabilised polymeric silicate compositions
JP2023520709A (ja) 肝疾患と関連する鉄欠乏症の治療または予防における使用のためのカルボン酸塩リガンド修飾水酸化第二鉄組成物
CA3033422C (en) Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
US20200023004A1 (en) Bioproduct based on selenium nanoparticles in a honey matrix for the treatment of complex injuries and dermatological infections
SINGH CLAY AS A DRUG CARRIER
EVA et al. Physical-Chemical Issues of Cephalosporin Intercalated Nanoparticles for Life-Threatening Infections Treatment
MX2010005475A (es) La lidocaina como transformadora y productora de complejos de farmacos trasformados aplicados en nanodosis mediante implantes por inyeccion como dispositivos de liberacion prolongada.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200108

Address after: UK

Patentee after: British Research and Innovation Agency

Address before: Swindon, Wiltshire, UK

Patentee before: Nat Inst For Medical Res